Cargando…
A metastatic tumor is no different to a viral pandemic: lessons learnt from COVID-19 may teach us to change the PRRT paradigm
Autores principales: | Paganelli, Giovanni, Bodei, Lisa, Modlin, Irvin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7305056/ https://www.ncbi.nlm.nih.gov/pubmed/32564170 http://dx.doi.org/10.1007/s00259-020-04904-w |
Ejemplares similares
-
Blood transcript analysis and metastatic recurrent small bowel carcinoid management
por: Modlin, Irvin M, et al.
Publicado: (2014) -
Imaging and liquid biopsy in the prediction and evaluation of response to PRRT in neuroendocrine tumors: implications for patient management
por: Roll, Wolfgang, et al.
Publicado: (2021) -
Decoding the Molecular and Mutational Ambiguities of Gastroenteropancreatic Neuroendocrine Neoplasm Pathobiology
por: Kidd, Mark, et al.
Publicado: (2015) -
New Insights in PRRT: Lessons From 2021
por: Puliani, Giulia, et al.
Publicado: (2022) -
A PCR blood test outperforms chromogranin A in carcinoid detection and is unaffected by proton pump inhibitors
por: Modlin, Irvin M, et al.
Publicado: (2014)